Pharmacokinetic assessment of JUUL2 18 mg/mL electronic nicotine delivery system in four flavors relative to cigarettes and a 5% (58 mg/mL) nicotine pod-based electronic nicotine delivery system among adult dual users.
Experimental and Clinical Psychopharmacology · 10.08.2026
DOI: 10.1037/pha0000873 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Psychopharmacology, online erschienen am 10.08.2026. Verfasst von Nicholas I Goldenson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Juul Labs. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Gefördert von: Juul Labs.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Juul Labs.
- PinneyAssociates.
ORCID-Profile: Nicholas I Goldenson
Förderung
- Juul Labs
Zitieren
APA
Goldenson, N. I., Oliveri, D. R., Liang, Q., & Shiffman, S. (2026). Pharmacokinetic assessment of JUUL2 18 mg/mL electronic nicotine delivery system in four flavors relative to cigarettes and a 5% (58 mg/mL) nicotine pod-based electronic nicotine delivery system among adult dual users. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000873
Vancouver
Goldenson NI, Oliveri DR, Liang Q, Shiffman S. Pharmacokinetic assessment of JUUL2 18 mg/mL electronic nicotine delivery system in four flavors relative to cigarettes and a 5% (58 mg/mL) nicotine pod-based electronic nicotine delivery system among adult dual users. Experimental and Clinical Psychopharmacology. 2026. doi:10.1037/pha0000873
BibTeX
@article{Goldenson2026,
author = {Goldenson, Nicholas I and Oliveri, Douglas R and Liang, Qiwei and Shiffman, Saul},
title = {Pharmacokinetic assessment of JUUL2 18 mg/mL electronic nicotine delivery system in four flavors relative to cigarettes and a 5% (58 mg/mL) nicotine pod-based electronic nicotine delivery system among adult dual users},
journal = {Experimental and Clinical Psychopharmacology},
year = {2026},
doi = {10.1037/pha0000873}
}
EUVIMED